Search Femetric

Search peptides, goals, protocols and references

SIGNATURE TOOL · SIDE-BY-SIDE RESEARCH

Compare Peptides

Compare structured records, protocol sources, women-specific metadata and connected research without collapsing unlike evidence into one score.

VS

At a glance

FIELDMOTS-CSS-31 / Elamipretide
Record typeSingle peptideSingle peptide
Research contextMitochondrial-derived peptideMitochondria-targeted tetrapeptide
Routes indexedSubcutaneous researchSubcutaneous
Last reviewed2026-09-092026-09-13

Research goals

FIELDMOTS-CSS-31 / Elamipretide
Goal tagsMitochondrial Health · Energy · Metabolic · Endurance · Healthy AgingMitochondrial Health · Energy · Cellular Repair · Healthy Aging
Research areasMitochondria · Energy · EnduranceMitochondrial Health · Energy · Cellular Repair · Healthy Aging

Protocol structure

FIELDMOTS-CSS-31 / Elamipretide
Variations indexed11
Primary frequency3× weeklySee indexed source
Duration4 weeks0 weeks
Stage detailCOMPLETEPENDING SOURCE EXTRACTION

Study / reference context

FIELDMOTS-CSS-31 / Elamipretide
Protocol sourcePLACEHOLDER / UNVERIFIED · Femetric planning field under editorial reviewLITERATURE-DERIVED REFERENCE · U.S. Food and Drug Administration, 2025
Indexed references41
Reference typesPRECLINICAL · REVIEW · HUMANREGULATORY

Related goals

MOTS-C
SS-31 / Elamipretide

References

MOTS-CThe mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistancePRECLINICAL · 2015MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolismREVIEW · 2016The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivityPRECLINICAL · 2019MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasisHUMAN · 2021
SS-31 / ElamipretideFORZINITY (elamipretide) prescribing informationREGULATORY · 2025
NEXT

Explore related comparisons

NEXT RESEARCH ACTION
Was this useful?